Characterization of a Retinal Melatonin Receptor
Overview
Authors
Affiliations
Melatonin (5-methoxy-N-acetyltryptamine) at picomolar concentrations (IC50, 40 pM) inhibited the calcium-dependent release of [3H]dopamine elicited at 3 Hz (2 min, 20 mA, 2 msec) from rabbit retina through activation of a site possessing the pharmacological and functional characteristics of a receptor. The effect of melatonin shows biological specificity as this hormone does not modify [3H]dopamine release from striatum or olfactory tubercle. This paper describes the effects of small modifications of the melatonin structure on the inhibition of calcium-dependent release of [3H]dopamine from retina. The more active melatonin analogs were those possessing a 5-methoxy group on carbon 5 of the indole nucleus and an N-acetyl group on the same position as in melatonin. The potencies of 5-methoxy indoles compounds was as follows (IC50): melatonin (40 pM) = 6-chloromelatonin (40 pM) greater than 6-hydroxymelatonin (1.6 nM) greater than or equal to 6-methoxymelatonin (2 nM) greater than 5-methoxytryptamine (63 nM) greater than 5-methoxy-N,N-di-methyltryptamine (200 nM) much greater than 5-methoxytryptophol (4 microM). The structure activity relationships of melatonin and related indoles indicated that the efficacy of melatonin is determined by the moiety substituted on carbon 5 (i.e., 5-methoxy group), whereas the affinity for the receptor is determined primarily by the moiety substituted on carbon 3 (i.e., ethyl N-acetyl group) of the indole nucleus. N-acetyltryptamine competitively antagonized the inhibitory effect of melatonin in the chicken retina and appears to be a partial agonist in the rabbit retina.(ABSTRACT TRUNCATED AT 250 WORDS)
Structural Basis for Agonistic Activity and Selectivity toward Melatonin Receptors MT1 and MT2.
Cantarini M, Rusciano D, Amato R, Canovai A, Cammalleri M, Dal Monte M Int J Mol Sci. 2023; 24(3).
PMID: 36769183 PMC: 9918025. DOI: 10.3390/ijms24032863.
Circadian regulation in the retina: From molecules to network.
Ko G Eur J Neurosci. 2018; 51(1):194-216.
PMID: 30270466 PMC: 6441387. DOI: 10.1111/ejn.14185.
Daily Rhythm in Plasma N-acetyltryptamine.
Backlund P, Urbanski H, Doll M, Hein D, Bozinoski M, Mason C J Biol Rhythms. 2017; 32(3):195-211.
PMID: 28466676 PMC: 5571864. DOI: 10.1177/0748730417700458.
Update on melatonin receptors: IUPHAR Review 20.
Jockers R, Delagrange P, Dubocovich M, Markus R, Renault N, Tosini G Br J Pharmacol. 2016; 173(18):2702-25.
PMID: 27314810 PMC: 4995287. DOI: 10.1111/bph.13536.
Dubocovich M, Delagrange P, Krause D, Sugden D, Cardinali D, Olcese J Pharmacol Rev. 2010; 62(3):343-80.
PMID: 20605968 PMC: 2964901. DOI: 10.1124/pr.110.002832.